No Data
No Data
No Data
No Data
No Data
Earnings Call Summary | Arbutus Biopharma(ABUS.US) Q1 2024 Earnings Conference
The following is a summary of the Arbutus Biopharma Corporation (ABUS) Q1 2024 Earnings Call Transcript:Financial Performance:Arbutus ended Q1 2024 with cash, cash equivalents, and investments of arou
moomoo AI18:21 ET · Conference Call
Arbutus Biopharma CSO Sets Retirement Date
TipRanksMay 2 08:11 ET
Express News | Arbutus Biopharma Corp - Qtrly Shr Loss $0.10
ReutersMay 2 07:36 ET
Express News | Arbutus Biopharma Corp - Expected Cash Runway Now Through Q2 of 2026
ReutersMay 2 07:35 ET
Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M, Vs. Street Est of $3.7M
07:34 AM EDT, 05/02/2024 (MT Newswires) -- Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M, vs. Street Est of $3.7M
MT NewswiresMay 2 07:34 ET
Arbutus Biopharma Q1 EPS $(0.10) Beats $(0.11) Estimate, Sales $1.53M Miss $2.15M Estimate
Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is unchanged from the same period last year.
BenzingaMay 2 07:31 ET
No Data
No Data
Mcsnacks H TupackOP : No resistance